Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease.

Eran Zittan,A Hillary Steinhart, Pavel Goldstein,Raquel Milgrom,Ian M Gralnek,Mark S Silverberg

Clinical and translational gastroenterology（2021）

引用 3|浏览7

暂无评分

摘要

In individuals with Crohn's disease, higher adalimumab drug levels at week 4 (>13.9 μg/mL) were significantly associated with biological remission at week 24.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要